USAC TXSE Natural Gas Transmission Financials FY2016βFY2025
USA Compression Partners, LP had $998M of revenue in fiscal 2025, up 5.0% on the year before. Over five years, revenue changed +8.4% a year on average.
Last close Β· Oct 23, 2026
$25.05
0.1%Hi! I read USA Compression Partners, LPβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+5.0%
Yes. Sales grew 5.0% last year.
Does it make a profit?
11.2%
Yes. It keeps 11.2% of every sale as profit.
Does profit turn into cash?
27.8%
Yes. 27.8% of sales ends up as free cash.
Is debt under control?
4.3x
Heavy. Repaying its debt would take 4.3 years of operating profit.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
29.5x
One share costs 29.5 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days USA Compression Partners, LP did it, and the next one. Share prices often move a lot on those days.
Next results
November 4, 2026
Wednesday Β· in 10 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 4, 2026 | Q2 '26 | Before the market opens | 8-K β |
| May 5, 2026 | Q1 '26 | Before the market opens | 8-K β |
| Feb 17, 2026 | Q4 '25 | Before the market opens | 8-K β |
| Nov 5, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Aug 6, 2025 | Q2 '25 | Before the market opens | 8-K β |
| May 6, 2025 | Q1 '25 | Before the market opens | 8-K β |
| Feb 11, 2025 | Q4 '24 | Before the market opens | 8-K β |
| Nov 5, 2024 | Q3 '24 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· USA Compression Partners, LP had $998M of revenue in fiscal 2025, up 5.0% on the year before. Over five years, revenue changed +8.4% a year on average. Its operating margin was 30.7%, down 0.3Β pts: of every 100 in sales, about 31 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· USA Compression Partners, LP made $111M of net profit in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $277M in fiscal 2025, 27.8% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· USA Compression Partners, LP owes $2.5B more than it holds in cash, about 4.3 years of operating profit.
Cash, debt and the ratios that show how comfortably USA Compression Partners, LP can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.0M | $0.0M | $0.0M | $0.0M | $8.6M |
| Debt incl. finance leases | $2.0B | $2.1B | $2.3B | $2.5B | $2.5B |
| Net debt / EBITDA | 5.2x | 5.2x | 4.9x | 4.5x | 4.3x |
| Interest coverage | 1.1x | 1.2x | 1.4x | 1.5x | 1.6x |
| Current ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.3x |
| Quick ratio | 0.6x | 0.5x | 0.6x | 0.5x | 0.5x |
| Total assets | $2.8B | $2.7B | $2.7B | $2.7B | $2.6B |
| Total liabilities | $2.2B | $2.3B | $2.6B | $2.7B | $2.7B |
| Net debt (β = net cash) | $2.0B | $2.1B | $2.3B | $2.5B | $2.5B |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· USA Compression Partners, LP passes 6 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 3 / 7 | 5 / 7 | 3 / 7 | 5 / 8 | 5 / 8 | 6 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | β10.7% | β25.1% | β8.6% | β7.0% | β26.6% | β8.9% | β8.5% | β7.5% | β8.8% | β10.5% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $264M | $277M | $584M | $698M | $668M | $633M | $705M | $846M | $950M | $998M |
| Operating income | β$27.0M | β$263M | $65.3M | $168M | β$465M | $141M | $169M | $232M | $294M | $307M |
| Interest expense | $21.1M | $0.0M | $78.4M | $127M | $129M | $130M | $138M | $170M | $193M | $187M |
| Pretax income | β$27.1M | β$263M | β$13.0M | $41.3M | β$593M | $11.2M | $31.3M | $69.6M | $102M | $116M |
| Income tax | β$0.2M | $1.8M | β$2.5M | $2.2M | $1.3M | $0.9M | $1.0M | $1.4M | $2.2M | $4.9M |
| Net income | β$26.9M | β$265M | β$10.6M | $39.1M | β$595M | $10.3M | $30.3M | $68.3M | $99.6M | $111M |
| Diluted EPS | β | β | β | β | β$6.65 | β$0.40 | β$0.19 | $0.20 | $0.72 | $0.85 |
| Diluted shares | β | β | β | β | 0.10B | 0.10B | 0.10B | 0.10B | 0.11B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $130M | $136M | $226M | $301M | $293M | $265M | $261M | $272M | $341M | $394M |
| Capital expenditure | $61.6M | $157M | $267M | $171M | $109M | $45.2M | $134M | $239M | $205M | $117M |
| Free cash flow | $68.5M | β$21.3M | β$40.2M | $129M | $184M | $220M | $126M | $33.4M | $136M | $277M |
| Depreciation and amortization | $155M | $167M | $214M | $231M | $239M | $239M | $237M | $246M | $265M | $285M |
| Stock-based compensation | $3.5M | $4.0M | $11.7M | $10.8M | $8.4M | $15.5M | $15.9M | $22.2M | $16.6M | $4.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $14.2M | $4.0M | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $8.6M |
| Total debt | $685M | $783M | $1.8B | $1.9B | $1.9B | $2.0B | $2.1B | $2.3B | $2.5B | $2.5B |
| Finance lease liabilities | β | β | β | $2.3M | $1.6M | $1.4M | $1.7M | $1.2M | $1.5M | $1.1M |
| Current assets | $73.0M | $74.2M | $218M | $231M | $200M | $205M | $186M | $226M | $235M | $237M |
| Current liabilities | $56.4M | $47.1M | $150M | $189M | $170M | $188M | $174M | $188M | $191M | $187M |
| Inventory | $29.6M | $33.2M | $89.0M | $91.9M | $84.6M | $85.8M | $93.8M | $115M | $134M | $134M |
| Property and equipment, net | $1.3B | $1.2B | $2.5B | $2.5B | β | β | β | β | β | β |
| Goodwill | $35.9M | $253M | $619M | $619M | $0.0M | β | β | β | β | $0.0M |
| Intangible assets | $75.2M | $198M | $393M | $363M | $334M | $304M | $275M | $246M | $216M | $187M |
| Total assets | $1.5B | $1.7B | $3.8B | $3.7B | $2.9B | $2.8B | $2.7B | $2.7B | $2.7B | $2.6B |
| Total liabilities | β | $54.1M | $1.9B | $2.1B | $2.1B | $2.2B | $2.3B | $2.6B | $2.7B | $2.7B |
| Margins | ||||||||||
| Operating margin | β10.2% | β94.9% | 11.2% | 24.1% | β69.6% | 22.3% | 24.0% | 27.4% | 31.0% | 30.7% |
| EBITDA margin | 48.6% | β34.7% | 47.7% | 57.3% | β33.8% | 60.0% | 57.6% | 56.5% | 58.8% | 59.2% |
| Net margin | β10.2% | β95.7% | β1.8% | 5.6% | β89.1% | 1.6% | 4.3% | 8.1% | 10.5% | 11.2% |
| FCF margin | 25.9% | β7.7% | β6.9% | 18.5% | 27.6% | 34.8% | 17.9% | 3.9% | 14.4% | 27.8% |
| Returns | ||||||||||
| Return on capital employed | β1.9% | β15.7% | 1.8% | 4.8% | β16.7% | 5.5% | 6.8% | 9.1% | 11.5% | 12.6% |
| Return on assets | β1.8% | β16.6% | β0.4% | 1.0% | β17.8% | 0.4% | 1.1% | 2.5% | 3.6% | 4.1% |
| Growth | ||||||||||
| Revenue growth | β | 4.8% | 111.2% | 19.5% | β4.4% | β5.2% | 11.4% | 20.1% | 12.3% | 5.0% |
| Net income growth | β | β | β | β | β1,619.8% | β | 195.0% | 125.2% | 45.9% | 11.8% |
| EPS growth | β | β | β | β | β | β | β | β | 260.0% | 18.1% |
| FCF growth | β | β131.2% | β | β | 42.3% | 19.6% | β42.6% | β73.6% | 309.1% | 102.9% |
| Share count change | β | β | β | β | β | 0.3% | 0.7% | 3.0% | 13.7% | 5.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 5.2x | β | 6.3x | 4.6x | β | 5.2x | 5.2x | 4.9x | 4.5x | 4.3x |
| Interest coverage | β1.3x | β | 0.8x | 1.3x | β3.6x | 1.1x | 1.2x | 1.4x | 1.5x | 1.6x |
| Current ratio | 1.3x | 1.6x | 1.5x | 1.2x | 1.2x | 1.1x | 1.1x | 1.2x | 1.2x | 1.3x |
| Quick ratio | 0.8x | 0.9x | 0.9x | 0.7x | 0.7x | 0.6x | 0.5x | 0.6x | 0.5x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 23.3% | 56.9% | 45.6% | 24.5% | 16.3% | 7.1% | 19.0% | 28.2% | 21.6% | 11.8% |
| Stock comp / revenue | 1.3% | 1.5% | 2.0% | 1.5% | 1.3% | 2.5% | 2.3% | 2.6% | 1.7% | 0.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 5.0 | 3.0 | 5.0 | 5.0 | 6.0 | 6.0 | 6.0 |
| Accruals ratio | β10.7% | β25.1% | β8.6% | β7.0% | β26.6% | β8.9% | β8.5% | β7.5% | β8.8% | β10.5% |
Source: SEC EDGAR XBRL filings (CIK 0001522727). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
